Clinical Trial Details


Back to Clinical Trials Database

A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 26-Jul-2010
Date Step1 close: 02-Sep-2013
Date Step2 close: 27-Mar-2013
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 105 - All Groups: 105
Treatment Lenalidomide
Study Staff
Type of cancer
Participating groups EORTC Cutaneous Lymphoma Task Force
Protocol summary
NCT number NCT01098656
EudraCT 2009-011020-65